Abstract
Gastrointestinal NursingVol. 15, No. 2 NewsNewsSue LearnerSue LearnerSearch for more papers by this authorSue LearnerPublished Online:21 Mar 2017https://doi.org/10.12968/gasn.2017.15.2.8AboutSectionsView articleView Full TextPDF/EPUB ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareShare onFacebookTwitterLinked InEmail View article References Pombo-Rodrigues S, Hashem K, He F, MacGregor G (2017) Salt and sugars content of breakfast cereals in the UK from 1992 to 2015. Public Health Nutr (epub ahead of print). http://dx.doi.org/10.1017/S1368980016003463 Google ScholarConsensus Action on Salt and Health (2017) Breakfast cereals contain shocking levels of sugar (up to 35%) in spite of manufacturers' claims over the last 20 years. http://tinyurl.com/hjb2tcl (accessed 6 March 2017) Google ScholarECCO (2017) Breath test could help detect stomach and oesophageal cancers. http://tinyurl.com/zyeaz8z (accessed 6 March 2017) Google ScholarMarkar S, Wiggins T, Antonowicz S et al. (2017) Breath volatile organic compound analysis for the diagnosis of esophago-gastric cancer: multi-centre blinded validation clinical trial. Proceedings of the European Cancer Congress, Amsterdam, the Netherlands, 27–30 January 2017 Google ScholarKnapton S (2017) Parents should enforce ‘no seconds’ policy at mealtimes to prevent child obesity, says expert. The Daily Telegraph. http://tinyurl.com/h524lmg (accessed 16 February 2017) Google ScholarMarie Curie (2017) Palliative Care Knowledge Zone. mariecurie.org.uk/knowledgezone (accessed 16 February 2017) Google ScholarNHS England (2017) Provider-based Cancer Waiting Times for Q3 2016/17. http://tinyurl.com/zf35v78 (accessed 16 February 2017) Google ScholarSharp L, McDevitt J, Carsin AE et al. (2017) Smoking at diagnosis significantly decreases 5-year cancer-specific survival in a population-based cohort of 18 166 colon cancer patients. Aliment Pharmacol Ther (published online). http://dx.doi.org/10.1111/apt.13944 Google ScholarNeoptolemos J, Palmer D, Ghaneh P et al. (2017) Comparison of adjuvant gemcitabine and capecitabine with gemcitabine monotherapy in patients with resected pancreatic cancer (ESPAC-4). Lancet (published online). http://dx.doi.org/10.1016/s0140-6736(16)32409-6 Google Scholar FiguresReferencesRelatedDetails 2 March 2017Volume 15Issue 2ISSN (print): 1479-5248ISSN (online): 2052-2835 Metrics History Published online 21 March 2017 Published in print 2 March 2017 Information© MA Healthcare LimitedPDF download
Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
